<code id='8E16AA54BB'></code><style id='8E16AA54BB'></style>
    • <acronym id='8E16AA54BB'></acronym>
      <center id='8E16AA54BB'><center id='8E16AA54BB'><tfoot id='8E16AA54BB'></tfoot></center><abbr id='8E16AA54BB'><dir id='8E16AA54BB'><tfoot id='8E16AA54BB'></tfoot><noframes id='8E16AA54BB'>

    • <optgroup id='8E16AA54BB'><strike id='8E16AA54BB'><sup id='8E16AA54BB'></sup></strike><code id='8E16AA54BB'></code></optgroup>
        1. <b id='8E16AA54BB'><label id='8E16AA54BB'><select id='8E16AA54BB'><dt id='8E16AA54BB'><span id='8E16AA54BB'></span></dt></select></label></b><u id='8E16AA54BB'></u>
          <i id='8E16AA54BB'><strike id='8E16AA54BB'><tt id='8E16AA54BB'><pre id='8E16AA54BB'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:51638
          The cost of healthcare health technology assessment
          APStock

          Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments and surgery centers will get billions in new revenue.

          The base figure that determines how much physicians get paid by Medicare will decrease by 3.3% for 2024, the federal government said Thursday.

          advertisement

          The cuts will not be distributed equally among all specialties. Indeed, primary care doctors, endocrinologists, nurse practitioners, and physician assistants would see their Medicare payment rates rise, on average, according to the annual payment rule. Cuts would be steepest for all types of radiologists, including interventionalists and nuclear medicine, as well as vascular surgeons.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

          PeterMarks,theFDA'stopregulatorofgenetherapies(right),speakswithSTAT'sAdamFeuersteininSanFrancisco.S

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Q&A: Jennifer Adair on making gene therapy available globally

          JenniferAdairdevelopsscalable,lowcostgenetherapiesattheFredHutchinsonCancerCenterandhelpedfoundtheGl